Showing results (11-20 of 447) with videos related to
Sort By:
Pageof 45
Cardio-Oncology (London, England)|August 27, 2025
Management of primary central nervous system lymphoma and coexisting heart failure with reduced ejection fraction: a narrative reviewVanessa M Barrionuevo-Villacis, Mauricio X DavilaCardio-Oncology (London, England)|February 21, 2017
Crizotinib Inhibits Hyperpolarization-activated Cyclic Nucleotide-Gated Channel 4 ActivityZhushan Zhang, Tai-Qin Huang, Igor Nepliouev, et al.Cardio-Oncology (London, England)|January 31, 2017
Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasuresAnthony F Yu, Lee W JonesCardio-Oncology (London, England)|February 24, 2021
Competing mortality risks: predicted cardiovascular disease risk versus predicted risk of breast cancer mortality in patients receiving adjuvant chemotherapy in a single Irish centerLisa Prior, Hannah Featherstone, David O'Reilly, et al.Cardio-Oncology (London, England)|November 2, 2018
Risk of Coronary Events 55 Years after Thymic Irradiation in the Hempelmann CohortMichael Jacob Adams, Susan G Fisher, Steven E Lipshultz, et al.Cardio-Oncology (London, England)|September 7, 2022
A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA researchCameron Brown, Michael Mantzaris, Elpiniki Nicolaou, et al.Cardio-Oncology (London, England)|March 26, 2021
Management strategies and clinical outcomes in breast cancer patients who develop left ventricular dysfunction during trastuzumab therapyRen Jie Robert Yao, Jordan Gibson, Christine Simmons, et al.Cardio-Oncology (London, England)|February 5, 2025
Screening for coronary artery disease among cancer survivors: rationale and design of the REDEEM-CAD studyCheng Hwee Soh, Joel Smith, Shristy Shrestha, et al.Cardio-Oncology (London, England)|February 5, 2025
Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213)Arnethea L Sutton, Nathaniel S O'Connell, Alexander R Lucas, et al.Cardio-Oncology (London, England)|January 30, 2025
Impact of advanced lung cancer inflammation index on all-cause mortality among patients with heart failure: a systematic review and meta-analysis with reconstructed time-to-event dataAhmed Mazen Amin, Ramy Ghaly, Hossam Elbenawi, et al.Pageof 45